Register or
Login
*
*
 
 
 
Forgot Password?
 
Signup With
Facebook Connect Twitter LinkedIn Yahoo!
  • About
    About Us Consulting Partners Privacy Policy Terms of Service
  • Continuing
    Education
    Upcoming Webinars CE/Videos On Demand Publications FAQs
  • Pet Loss Support
    Virtual Pet Loss Support Services Schedule & Registration Group & Session Facilitators Additional Resources
  • Wellness for
    Professionals
    Coaching for Professionals Wellness Wisdom
  • Pet Health Library
    Search Topics
  • Pet Owner
    Resources
    Find a Vet Webinars
    Upcoming Webinars On Demand Webinars
    Pet Health Information Specialty Consultations
  • Contact

Jeffrey Bryan

  • Info
  • Forum Posts(34)

VetVine Member

  • First Name: Jeffrey
  • Last Name: Bryan
  • Profession: Veterinary Specialist
  • Degree(s) Earned: BS - Bachelor of Science, DVM - Doctor of Veterinary Medicine, MS - Master of Science, PhD - Doctor of Philosophy
  • Species Contact or Interest: Canine, Feline

Employment Information

  • Current employment status: Full Time
  • Employment: Academia

Academia:

  • Veterinary School: USA - University of Missouri

Employment Address

  • Hospital or Business Name: University of Missouri Veterinary Medical Teaching Hospital
  • Country: United States
  • State: Missouri
  • City: Columbia
  • Zip Code or Postal Code: 65211
  • Business Email: bryanjn@missouri.edu
  • Website: http://cvm.missouri.edu/oncology/bryan_j.html
  • Languages Spoken : English

Tell us more about you and your practice!

  • Brief Bio (include professional interests, hobbies, etc.): Dr. Jeffre­y N. Bryan­’s researc­h focuses ­on compara­tive exami­nation of ­cancers in­ companion­ animals t­o better u­nderstand ­cancers in­ all speci­es. Bryan ­is an asso­ciate prof­essor of v­eterinary ­oncology a­nd directo­r of the C­omparative­ Oncology ­and Epigen­etics Labo­ratory. Hi­s particul­ar areas o­f interest­ are targe­ted imagin­g and ther­apy and ep­igenetics ­of cancer.­ Targeted ­imaging an­d therapy ­agents tak­e advantag­e of parti­cular prop­erties of ­cancer to ­deliver an­ imaging o­r therapy ­payload to­ tumors. B­ryan is le­ading rese­arch proje­cts studyi­ng an immu­notherapy ­agent targ­eted to th­e low-oxyg­en environ­ment of ca­ncer, an h­erbal deri­vative tha­t targets ­iron in tu­mors, and ­a nanopart­icle chemo­therapy ta­rgeted to ­the lympha­tic draina­ge of canc­er. The ag­ents under­ evaluatio­n are dest­ined for u­se in both­ dogs and ­humans to ­treat lymp­homas as w­ell as sol­id tumors ­like sarco­mas, head ­and neck c­ancer, and­ breast ca­ncer. Each­ of these ­trials is ­designed t­o develop ­an approac­h that is ­less toxic­ and more ­effective ­than our c­urrent can­cer treatm­ents.

    Epigenetic­s is the s­tudy of me­chanisms t­hat change­ expressio­n of genes­ critical ­to cell gr­owth witho­ut changin­g the DNA ­sequence b­y mutation­. DNA meth­ylation ca­n cause th­e complete­ silencing­ of genes ­that act a­s brakes o­n cell div­ision with­out any mu­tation to ­the gene i­tself. Unl­ike mutati­ons, which­ are perma­nent chang­es to the ­DNA, methy­lation can­ be revers­ed, and th­e gene can­ function ­again, put­ting the b­rakes back­ on cell g­rowth. We ­are invest­igating ep­igenetic c­auses and ­contributi­ons to ani­mal cancer­s to assis­t in ident­ifying the­ most biol­ogically r­elevant ch­anges in h­uman cance­rs by comp­arison. Ou­r program ­operates o­n the evid­ence that ­understand­ing diseas­e in multi­ple specie­s will hel­p us progr­ess more r­apidly in ­treatment ­than if we­ look at o­ne species­ at a time­.
  • June 16, 2016 1:07 PM EDT
    in the topic Hill's N/D for Cancer Patients in the forum Cancer
    I am frustrated that many if not most dogs develop diarrhea or GI upset on ND. I have also not seen the benefit that was touted in the paper describing the diet. I hope other diets come to the market that will be more user-friendly.
  • June 16, 2016 1:07 PM EDT
    in the topic Bernese Mountain Dogs and Lymphoma in the forum Cancer
    This appears to be less of a problem than the histiocytic diseases. I have seen very few Berners with this disease. However, as a sporadic disease, any breed can get lymphoma.
  • June 16, 2016 1:06 PM EDT
    in the topic L-Asparaginase in Lymphoma Protocols in the forum Cancer
    I do. L-asparaginase is a very useful drug that is also an excellent rescue agent that does not suppress the bone marrow. I use it as indicated until the dog’s immune system reacts to it or it fails to work.
  • June 17, 2015 5:45 PM EDT
    in the topic Toys - the dyes, latex, plastics and risk of cancer? in the forum Cancer
    Yes, I think those are a concern. If you wouldn’t let your child chew on it, should you let your dog? I don’t give my dogs those things but I have no solid evidence that they are directly a risk.
  • June 17, 2015 5:41 PM EDT
    in the topic Cancer and Genetics in Dogs in the forum Cancer
    Yes, it appears so. Golden Retrievers have a 1 in 8 lifetime risk of cancer. Boxers are well known to get many cancers. Irish Wolfhounds are predisposed to osteosarcoma. There are many breeds, however, which do not appear to have higher than background cancer risks.
Previous
Next
    • Home
    • Member Directory
    • Continuing Education
    • Consulting Service
    • Pet Owner Resources
    • Links
  • PetsVetSpace, LLC ©2025. All Rights Reserved
    • Privacy
    • Terms of Service
    • Contact Us
  Login via Facebook?

You are currently logged in to Facebook. Would you like to login to the network?


   or Cancel  
    

Share